Sign in
Not yet taking people in United StatesNo phase

Kore Fiber PLF Study

Key facts

Who runs it
Kolosis Bio, LLC
Where
Columbus, United StatesSee the site
Trial code
Status
Not yet recruiting
People taking part
75 people, planned
Started
Nov 2026
Expected to end
Nov 2028
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Kore Fiber
  • Autologous bone graft
Record updated
22 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 14 criteriaShow less

Who can take part

  • Age ≥18 years
  • Is undergoing standard of care of one- to four-level instrumented posterolateral fusion between L1 and S1
  • Has failed 6 months or more of conservative, non-operative treatment
  • Able to provide informed consent
  • Agree to comply with study protocol

Who cannot take part

  • Prior lumbar fusion surgery at the index levels planned for study treatment
  • Minimally invasive/tubular surgery
  • Active or recent malignancy (within 3 years), or current treatment with chemotherapy, radiation, immunosuppressive agents, or chronic steroids
  • History of osteoporosis, osteopenia, osteomalacia, or osteoporotic fracture that may compromise fusion outcomes
  • Active systemic infection or localized infection at the operative site
  • Cognitive, psychological, or neurological condition that may interfere with pain assessment or study compliance
  • Pregnant or planning pregnancy during the study period
  • Member of a vulnerable population (e.g., prisoners, cognitively impaired, unable to consent)
  • Body mass index (BMI) > 45 kg/m²

Where in United States

  • The Ohio State University -Wexner Medical CenterColumbus, United StatesContact: Clinical Research ManagerNot yet recruiting

About the trial

What the trial wants to find out

This is a prospective, randomized controlled trial evaluating Kore Fiber® versus autograft in adults undergoing posterolateral lumbar fusion (PLF). Participants will receive Kore Fiber on one side of the spine and autograft on the opposite side according to randomized assignment. Fusion outcomes, pain outcomes, and safety will be assessed over 12 months.

The 2 groups in the trial

  • Kore FiberTreatment being tested

    Kore fiber used standalone in instrumented posterolateral fusion per level at the randomized assigned side

  • Autologous bone graftExisting treatment, for comparison

    Autologous bone graft used in instrumented posterolateral fusion per level at the randomized assigned control side of the spine.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Prospective, Randomized Controlled Trial of Kore Fiber® Versus Autograft in Posterolateral Lumbar Fusion (PLF)
Record updated
22 October 2026